Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase Meeting Abstract


Authors: Fontana, E.; Lee, E.; Rosen, E.; Spigel, D.; Højgaard, M.; Lheureux, S.; Mettu, N. B.; Carter, L.; Plummer, R.; Manley, P.; Ulanet, D.; Rimkunas, V.; Silverman, I. M.; O'Connell, J.; McDougall, R.; Wainszelbaum, M.; Xu, Y.; Koehler, M.; Fretland, A. J.; Yap, T. A.
Abstract Title: Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase
Meeting Title: ESMO Targeted Anticancer Therapies Congress (TAT)
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 1
Meeting Dates: 2022 Mar 7-8
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-03-01
Start Page: S3
End Page: S4
Language: English
ACCESSION: WOS:000767330600006
DOI: 10.1016/j.annonc.2022.01.068
PROVIDER: wos
Notes: Meeting Abstract: 5MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ezra Y Rosen
    49 Rosen